Histopathology-guided mass spectrometry differentiates benign nevi from malignant melanoma.
Journal:
Journal of cutaneous pathology
Published Date:
Nov 27, 2019
Abstract
PURPOSE: Distinguishing benign nevi from malignant melanoma using current histopathological criteria may be very challenging and is one the most difficult areas in dermatopathology. The goal of this study was to identify proteomic differences, which would more reliably differentiate between benign and malignant melanocytic lesions.